Literature DB >> 10634554

Activated protein C resistance and anticoagulant proteins in young adults with central retinal vein occlusion.

J Larsson1, A Hillarp, E Olafsdottir, B Bauer.   

Abstract

BACKGROUND: Central retinal vein occlusion is a disease that is most common in old people, and often associated with atherosclerosis, hypertension, diabetes or glaucoma. Since these diseases are much less evident in young people, we wanted to investigate the prevalence of disorders in the most common anticoagulant proteins in a group of young patients with central retinal vein occlusion.
METHODS: 37 consecutive patients younger than 50 years and with a history of central retinal vein occlusion, were analysed for deficiencies of natural inhibitors of coagulation (protein C, S, and antithrombin III), plasminogen, resistance to activated protein C, and the presence of anticardiolipin or lupus anticoagulants.
RESULTS: Anticoagulant protein deficiencies were found in 4 patients (11%) and activated protein C resistance in 7 patients (19%). Anticardiolipin or lupus anticoagulants were not found in the patients.
CONCLUSION: Activated protein C resistance and anticoagulant protein deficiencies seem to be important factors to the etiology to central retinal vein occlusion in young patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10634554     DOI: 10.1034/j.1600-0420.1999.770606.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  8 in total

1.  Central retinal vein occlusion in a young Chinese population: risk factors and associated morbidity and mortality.

Authors:  Jane Zea-Chin Kuo; Chi-Chun Lai; Frank Shih-Chang Ong; Chia-Pang Shih; Ling Yeung; Tun-Lu Chen; Kuan-Jen Chen; Wei-Chi Wu
Journal:  Retina       Date:  2010-03       Impact factor: 4.256

2.  [Retinal vein branch occlusion and palsy of the N. abducens in protein S deficiency].

Authors:  H M Holak; N H Holak; S Holak; S A Holak; S Szymaniec
Journal:  Ophthalmologe       Date:  2005-03       Impact factor: 1.059

3.  Venous thromboembolism does not share familial susceptibility with retinal vascular occlusion or glaucoma: a nationwide family study.

Authors:  Bengt Zöller; Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  J Thromb Thrombolysis       Date:  2016-11       Impact factor: 2.300

4.  Anterior chamber depth and angle-closure glaucoma after central retinal vein occlusion.

Authors:  Shiu-Chen Wu; Yung-Sung Lee; Wei-Chi Wu; Shirley H L Chang
Journal:  BMC Ophthalmol       Date:  2016-05-31       Impact factor: 2.209

5.  Central Retinal Vein Occlusion in Younger Swedish Adults: Case Reports and Review of the Literature.

Authors:  Elisabeth Wittström
Journal:  Open Ophthalmol J       Date:  2017-05-22

6.  Thrombophilia and retinal vascular occlusion.

Authors:  Charles J Glueck; Robert K Hutchins; Joel Jurantee; Zia Khan; Ping Wang
Journal:  Clin Ophthalmol       Date:  2012-08-28

Review 7.  Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities.

Authors:  Jiri Rehak; Matus Rehak
Journal:  Curr Eye Res       Date:  2008-02       Impact factor: 2.424

8.  Retinal vascular occlusion: a window to diagnosis of familial and acquired thrombophilia and hypofibrinolysis, with important ramifications for pregnancy outcomes.

Authors:  Stephan G Dixon; Carl T Bruce; Charles J Glueck; Robert A Sisk; Robert K Hutchins; Vybhav Jetty; Ping Wang
Journal:  Clin Ophthalmol       Date:  2016-08-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.